The rising incidence of breast cancer underscores the critical need for accurate and early detection methods, particularly for key biomarkers like human epidermal growth factor receptor 2 (HER2). Here, a synergistic signal amplification electrochemical biosensor was developed for HER2 detection that utilizes tetrahedral DNA nanostructures (TDN), 2D transition metal carbon/nitride@Au (MXene@Au) composites, and activators regenerated by electron transfer atom transfer radical polymerization (ARGET ATRP). Specifically, TDN serves as the substrate, with the aptamer anchored by the MXene@Au composite support matrix. This design facilitates the generation of electrochemical currents through the ARGET ATRP signal amplification strategy. The robustness and high affinity of TDN minimize surface effects on the electrode and enhance target binding. Additionally, the high conductivity of the MXene@Au composites improves the detection sensitivity of the biosensor. The use of the ARGET ATRP strategy further enhances detection sensitivity. The biosensor exhibits a wide detection range from 10 pg·mL−1 to 10 µg·mL−1 with a remarkable detection limit of 0.39 pg·mL−1, verified under optimal experimental conditions. The designed biosensor offers a significant advancement in the field of oncological diagnostics, providing a highly sensitive, low-cost, and simple method for early HER2 detection, thereby potentially improving treatment outcomes for breast cancer patients.